Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 4Venous Thromboembolism 3Treatment of Venous Thromboembolism in Cancer Patients 3Venous Thrombosis 1Thromboembolism 1Pulmonary Embolism 1Pancreatic Neoplasms 1Multiple Myeloma 1Motor Activity 1Liver Neoplasms 1Liver Diseases 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Dalteparin 7apixaban 6Rivaroxaban 3edoxaban 2bemiparin 2Warfarin 2Tinzaparin 2Fondaparinux 2Enoxaparin 2Dabigatran 2Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin, Low-Molecular-Weight 1Heparin 1Aspirin 1Acetylcysteine 1Acenocoumarol 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pulmonary Embolism × Heparin, Low-Molecular-Weight × Clear all
NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡